Vyome Holdings (HIND) Operating Margin Growth (5y) (2020 - 2026)
Vyome Holdings (HIND) Operating Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -309,549.00 |
| Mar 31, 2026 | -350,671.00 |
| Dec 31, 2025 | -360,744.00 |
| Sep 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | -4,624.00 |
| Mar 31, 2025 | 52,941.00 |
| Dec 31, 2024 | 20,512.00 |
| Sep 30, 2024 | 91,492.00 |
| Jun 30, 2024 | 149,872.00 |
| Mar 31, 2024 | 34,265.00 |
| Dec 31, 2023 | 32,973.00 |
| Sep 30, 2023 | 4,112.00 |
| Jun 30, 2023 | 17,923.00 |
| Mar 31, 2023 | 68,209.00 |
| Dec 31, 2022 | -26,801.00 |
| Sep 30, 2022 | -11,176.00 |
| Jun 30, 2022 | 6,956.00 |
| Mar 31, 2022 | 18,999.00 |
| Sep 30, 2021 | 18,708.00 |
| Jun 30, 2021 | 41,857.00 |